慕思健康睡眠股份有限公司 关于 2025 年半年度募集资金存放、管理与使用情况 证券代码：001323 证券简称：慕思股份 公告编号：2025-056 的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 根据中国证券监督管理委员会（以下简称"中国证监会"）发布的《上市公 司募集资金监管规则》和深圳证券交易所颁布的《深圳证券交易所上市公司自律 监管指引第 1 号——主板上市公司规范运作》等法律、法规、规范性文件的要求， 慕思健康睡眠股份有限公司（以下简称"公司"或"本公司"）董事会编制了截 至 2025 年 6 月 30 日公司募集资金存放、管理与使用情况的专项报告，现将相关 情况说明如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 经中国证监会证监许可[2022]831 号文核准，并经深圳证券交易所同意，本 公司由主承销商招商证券股份有限公司通过深圳证券交易所系统采用网下向符 合条件的投资者询价配售与网上向持有深圳市场非限售 A 股和非限售存托凭证 市值的社会公众投资者定价发行相结合的方式，向社会公众公开发行人民币普通 股（A 股）4 ...

证券代码：001323 证券简称：慕思股份 公告编号：2025-059 重要提示 股东大会召开日期：2025 年 9 月 12 日 慕思健康睡眠股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 关于召开公司 2025 年第三次临时股东大会的通知 本次股东大会采用的网络投票系统：深圳证券交易所股东会网络投票系 统 根据《中华人民共和国公司法》及《公司章程》的有关规定，经慕思健康睡 眠股份有限公司（以下简称"公司"或"本公司"）第二届董事会第十六次会议 审议通过，决定于 2025 年 9 月 12 日（星期五）下午 14:50 召开公司 2025 年第 三次临时股东大会，现将本次股东大会的有关事项通知如下： 一、召开会议的基本情况 1、会议届次：2025 年第三次临时股东大会 2、会议召集人：公司董事会 3、会议召开的合法、合规性：公司第二届董事会第十六次会议审议通过了 《关于提请召开 2025 年第三次临时股东大会的议案》。本次股东大会会议召集、 召开符合有关法律、行政法规、部门规章、规范性文件以及《公司章程》的规定。 4、会议召开的日期和时间： （ ...

证券代码：001323 证券简称：慕思股份 公告编号：2025-053 慕思健康睡眠股份有限公司 具体内容详见公司同日刊登在《证券时报》《证券日报》《中国证券报》《上 海证券报》《经济参考报》及巨潮资讯网（http://www.cninfo.com.cn）的《2025 年半年度报告摘要》（公告编号：2025-055）以及刊登在巨潮资讯网的《2025 年 第二届监事会第十一次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 慕思健康睡眠股份有限公司（以下简称"公司"）第二届监事会第十一次会 议由监事会主席罗振彪先生召集，会议通知于 2025 年 8 月 15 日以邮件、微信、 电话的方式送达全体监事，并于 2025 年 8 月 27 日上午 11:00 以现场会议方式在 公司会议室召开。本次会议应出席监事 3 人，实际出席监事 3 人。会议由监事会 主席罗振彪先生主持，公司董事会秘书邓永辉先生列席本次会议。本次会议的出 席人数、召集、召开程序和议事内容均符合《中华人民共和国公司法》等相关法 律法规以及《公司章程》的相关规定，会 ...

证券代码：001323 证券简称：慕思股份 公告编号：2025-052 慕思健康睡眠股份有限公司 第二届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 慕思健康睡眠股份有限公司（以下简称"公司"）第二届董事会第十六次会 议由董事长王炳坤先生召集，会议通知于 2025 年 8 月 15 日以邮件、微信、电话 的方式送达全体董事和监事，并于 2025 年 8 月 27 日上午 10:00 以现场及通讯会 议方式在公司会议室召开。本次会议应出席董事 7 人，实际出席董事 7 人（其中 姚吉庆先生、盛艳女士、李飞德先生以通讯表决方式出席）。会议由董事长王炳 坤先生主持，公司全体监事及高级管理人员列席了会议。本次会议的出席人数、 召集、召开程序和议事内容均符合《中华人民共和国公司法》（以下简称"《公 司法》"）等相关法律法规和《公司章程》的相关规定，会议形成的决议合法有 效。 二、董事会会议审议情况 经与会各位董事认真审议，会议形成了如下决议： （一）审议通过《关于公司<2025 年半年度报告>及其摘要的议案》 根据《 ...

证券代码：001323 证券简称：慕思股份 公告编号：2025-057 慕思健康睡眠股份有限公司 关于 2025 年半年度利润分配预案的公告 （一）利润分配方案的基本内容 1、分配基准：2025 年半年度 2、根据《中华人民共和国公司法》（以下简称"《公司法》"）和《公司 章程》的有关规定，公司不存在需要弥补亏损、提取法定公积金、提取任意公积 金的情况。截至 2025 年 6 月 30 日，公司合并报表未分配利润为 1,350,628,786.48 元，母公司未分配利润为 1,185,081,431.39 元。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、审议程序 慕思健康睡眠股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开 了第二届董事会第十六次会议，以 7 票同意，0 票反对，0 票弃权的表决结果审 议通过了《关于公司 2025 年半年度利润分配预案的议案》；同日，公司召开了 第二届监事会第十一次会议，以 3 票同意，0 票反对，0 票弃权的表决结果审议 通过该议案。该议案尚需提交股东大会审议。 二、利润分配预案基本情况 （二 ...

Important Notice, Table of Contents, and Definitions [Important Notice](index=2&type=section&id=Important%20Notice) The company's board, supervisory board, and senior management guarantee the semi-annual report's truthfulness and completeness, with all directors attending and a 4.5 Yuan (tax inclusive) cash dividend per 10 shares proposed - The company's board of directors, supervisory board, and senior management guarantee the **truthfulness, accuracy, and completeness** of the semi-annual report, assuming individual and joint legal responsibility for no false statements, misleading representations, or major omissions[5](index=5&type=chunk) - Company head Wang Bingkun, chief accountant Deng Yonghui, and head of accounting department Deng Yonghui declare the financial report's **truthfulness, accuracy, and completeness**[5](index=5&type=chunk) 2025 Semi-Annual Profit Distribution Plan | Indicator | Amount/Description | | :--- | :--- | | Cash dividend per 10 shares (tax inclusive) | 4.5 Yuan | | Bonus shares | 0 shares | | Capital reserve to share capital | No transfer | [Table of Contents](index=3&type=section&id=Table%20of%20Contents) This section outlines the report's overall structure, covering nine main chapters including important notices, company profile, management discussion, corporate governance, significant matters, share changes, bond information, financial reports, and other submitted data - The report contains nine main chapters, covering comprehensive information on company operations, finance, governance, and significant matters[7](index=7&type=chunk) [List of Reference Documents](index=4&type=section&id=List%20of%20Reference%20Documents) This section lists reference documents, including the original report signed by the legal representative, financial statements, publicly disclosed documents, and other relevant files, all available at the company's securities department - Reference documents include the original report signed by the legal representative, financial statements, publicly disclosed documents, and other relevant files[9](index=9&type=chunk) - All reference documents are stored at the company's securities department[10](index=10&type=chunk) [Definitions](index=5&type=section&id=Definitions) This section defines key terms and abbreviations used in the report, covering company name, reporting period, currency units, subsidiary names, industry organizations, and terminology for clear understanding - The reporting period is defined as **January 1, 2025, to June 30, 2025**[11](index=11&type=chunk) - Mousse Co., Ltd. refers to Mousse Healthy Sleep Co., Ltd[11](index=11&type=chunk) - Definitions are provided for multiple subsidiaries, industry organizations (e.g., CSIL, Statista, Euromonitor International), and industry terms (e.g., JIT, VMI, KOL, C2M, O2O, IOT)[11](index=11&type=chunk) Company Profile and Key Financial Indicators [Company Profile](index=6&type=section&id=Company%20Profile) This section provides basic company information, including stock ticker, code, listing exchange, Chinese and English names, and legal representative Company Basic Information | Indicator | Content | | :--- | :--- | | Stock Abbreviation | Mousse Co., Ltd. | | Stock Code | 001323 | | Stock Exchange | Shenzhen Stock Exchange | | Chinese Name | 慕思健康睡眠股份有限公司 | | Legal Representative | Wang Bingkun | [Contact Person and Information](index=6&type=section&id=Contact%20Person%20and%20Information) This section provides contact information for the company's board secretary and securities affairs representative, including name, address, phone, fax, and email Company Contact Information | Position | Name | Phone | Email | | :--- | :--- | :--- | :--- | | Board Secretary | Deng Yonghui | 0769-85035088 | derucci-2021@derucci.com | | Securities Affairs Representative | Yang Nana | 0769-85035088 | derucci-2021@derucci.com | [Other Information](index=6&type=section&id=Other%20Information) This section states that the company's contact information, information disclosure, and document storage locations, along with other relevant data, remained unchanged during the reporting period, with details available in the 2024 annual report - The company's registered address, office address, website, and email remained unchanged during the reporting period[15](index=15&type=chunk) - Information disclosure and document storage locations remained unchanged during the reporting period[16](index=16&type=chunk) [Key Accounting Data and Financial Indicators](index=7&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) This section discloses the company's key accounting data and financial indicators for H1 2025, showing year-on-year decreases in operating revenue and net profit attributable to shareholders, with a significant drop in net cash flow from operating activities Key Accounting Data and Financial Indicators (Current Period vs. Prior Year) | Indicator | Current Period (Yuan) | Prior Year (Yuan) | YoY Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 2,477,600,271.92 | 2,629,136,482.55 | -5.76% | | Net Profit Attributable to Shareholders | 357,738,875.42 | 373,176,957.09 | -4.14% | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) | 285,272,504.96 | 360,958,493.79 | -20.97% | | Net Cash Flow from Operating Activities | 86,326,989.94 | 222,632,168.41 | -61.22% | | Basic Earnings Per Share (Yuan/share) | 0.91 | 0.95 | -4.21% | | Diluted Earnings Per Share (Yuan/share) | 0.91 | 0.95 | -4.21% | | Weighted Average Return on Net Assets | 7.62% | 7.90% | -0.28% | | **Current Period End vs. Prior Year End** | | | | | Total Assets | 7,545,044,002.90 | 7,678,660,424.67 | -1.74% | | Net Assets Attributable to Shareholders | 4,498,079,016.49 | 4,517,881,900.26 | -0.44% | - Net profit after deducting the impact of share-based payments was **381.01 million Yuan**[18](index=18&type=chunk) [Differences in Accounting Data under Domestic and Overseas Accounting Standards](index=7&type=section&id=Differences%20in%20Accounting%20Data%20under%20Domestic%20and%20Overseas%20Accounting%20Standards) This section declares no differences in net profit and net assets between financial reports disclosed under international or overseas accounting standards and Chinese accounting standards during the reporting period - The company's reporting period shows no differences in net profit and net assets between financial reports disclosed under international accounting standards and Chinese accounting standards[19](index=19&type=chunk) - The company's reporting period shows no differences in net profit and net assets between financial reports disclosed under overseas accounting standards and Chinese accounting standards[20](index=20&type=chunk) [Non-Recurring Gains and Losses Items and Amounts](index=7&type=section&id=Non-Recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) This section details non-recurring gains and losses for the reporting period, totaling **72.47 million Yuan**, primarily comprising fair value changes and government grants Non-Recurring Gains and Losses Items and Amounts | Item | Amount (Yuan) | Explanation | | :--- | :--- | :--- | | Disposal gains/losses of non-current assets | -721,581.76 | Asset disposal gains/losses | | Government grants recognized in current profit or loss | 13,344,765.89 | | | Gains/losses from changes in fair value of financial assets and liabilities held by non-financial enterprises, and gains/losses from disposal of financial assets and liabilities | 75,203,889.12 | | | Other non-operating income and expenses apart from the above | -765,583.67 | | | Other gains/losses items meeting the definition of non-recurring gains/losses | -79,857.86 | | | Less: Income tax impact | 14,515,261.26 | | | Total | 72,466,370.46 | | - The company has no other gains/losses items meeting the definition of non-recurring gains/losses, nor does it classify non-recurring gains/losses items as recurring gains/losses[23](index=23&type=chunk) Management Discussion and Analysis [Company's Main Business Activities During the Reporting Period](index=9&type=section&id=Company%27s%20Main%20Business%20Activities%20During%20the%20Reporting%20Period) This section details the company's unchanged main business in the soft furniture manufacturing industry, focusing on high-end mattresses as core products, and its commitment to health sleep research, global resource integration, and a customized sleep system through a diversified global sales network, also analyzing industry status, opportunities, and entry barriers [Company Business Overview](index=9&type=section&id=Company%20Business%20Overview) The company's main business is soft furniture manufacturing, focusing on high-end healthy sleep products and services, offering comprehensive solutions, with mattresses (including smart mattresses) as core products, supported by two digital smart manufacturing bases in South and East China, an overseas production base in Indonesia, and a global sales network - The company's main business is soft furniture manufacturing, with core products including high-end mattresses, bed frames, sofas, bedding, and other items, where **mattresses are the core product**[25](index=25&type=chunk) - The company operates two major digital smart manufacturing bases in South and East China, an overseas production base in Indonesia, and a sales network primarily based on distribution, complemented by e-commerce, direct supply, and direct sales channels[25](index=25&type=chunk) [Company's Main Products Introduction and Illustrations](index=9&type=section&id=Company%27s

Group 1 - The health sleep market in China is rapidly growing, with over 90% of the population experiencing sleep quality issues, leading to increased demand for health sleep products. The market size reached 499.58 billion yuan in 2023 and is expected to grow to 658.68 billion yuan by 2027, with a CAGR of 8.5% over ten years [1][2] - The penetration rate of smart mattresses is currently low, but the market is expanding quickly. From 2015 to 2023, the demand for smart mattresses in China increased from 93,000 units to 1.495 million units, representing a compound annual growth rate (CAGR) of 40.2% [2][3] - The smart mattress industry is expected to experience a new wave of rapid development due to advancements in AI algorithms and brain-machine interface technologies, with leading companies like Xilinmen, Mousse, and Qushui Technology launching AI mattress products [3][4] Group 2 - Leading companies are actively entering the health sleep ecosystem. Xilinmen has established a joint research center with Tsinghua University and launched the AI "Baobao·BrainCo" mattress, which utilizes non-invasive brain-machine interface technology [4] - Mousse plans to release the T11 series in 2024, which reduces sleep onset time by 37.3%, turning frequency by 34.2%, and waking frequency by 19.6%. The company is also collaborating with MIT to participate in the formulation of international smart sleep standards [4] - Qushui Technology is set to launch an "AI sleep monitoring improvement mattress" in 2024, integrating with the Mijia ecosystem to create a "sleep + life" integrated scenario, while also enhancing sleep monitoring algorithms in collaboration with ByteDance [4]

Core Viewpoint - The company Musi Health Sleep Co., Ltd. has announced a capital reserve transfer to increase share capital, which has been approved by the shareholders' meeting and will take effect in August 2025 [3][5]. Group 1: Trading Information - As of August 15, 2025, Musi shares closed at 32.09 yuan, with a slight increase of 0.09% and a turnover rate of 1.4% [1]. - The trading volume was 11,500 shares, with a total transaction amount of 36.8487 million yuan [1]. - On the same day, the net outflow of main funds was 4.9771 million yuan, while the net inflow from speculative funds and retail investors was 2.654 million yuan and 2.3232 million yuan, respectively [2][5]. Group 2: Company Announcements - The company has repurchased 2,376,612 shares, which will not participate in the capital reserve transfer [3]. - The transfer base is set at 393,367,411 shares after excluding the repurchased shares, with a ratio of 1 share for every 10 shares held, totaling 39,336,741 shares to be transferred [3]. - The ex-rights reference price will be calculated based on the closing price before the ex-rights date divided by one plus the per-share capital reserve transfer ratio [3]. - The equity registration date is August 20, 2025, and the ex-rights date is August 21, 2025 [3][5].

Core Viewpoint - The company has announced a capital reserve conversion plan for 2024, which has been approved by the shareholders' meeting, allowing for a distribution of shares to shareholders based on their holdings, with a ratio of 1 share for every 10 shares held [2][3]. Group 1: Capital Reserve Conversion Plan - The capital reserve conversion plan involves converting capital reserves into shares, with a total of 39,336,741 shares to be distributed, increasing the total share capital from 395,744,023 shares to 435,080,764 shares [2][3]. - The base for the conversion is calculated by deducting the repurchased shares (2,376,612 shares) from the total share capital [1][3]. - The conversion ratio is set at 1 share for every 10 shares held, and adjustments will be made if there are changes in total share capital due to stock options, convertible bonds, or other factors [3][6]. Group 2: Key Dates and Procedures - The record date for shareholders to be eligible for the share distribution is August 20, 2025, and the ex-rights date is August 21, 2025 [3][4]. - The shares resulting from the conversion will be credited directly to shareholders' accounts on the ex-rights date [4][5]. - Any fractional shares resulting from the conversion will be distributed based on a sorting method among shareholders [5]. Group 3: Share Structure Changes - The share structure before the conversion includes 313,987,100 restricted shares (79.34%) and 81,756,923 unrestricted shares (20.66%) [4]. - After the conversion, the restricted shares will increase to 345,385,810 (79.38%), while the unrestricted shares will be 89,694,954 (20.62%) [4]. - The final share capital structure will be confirmed by the China Securities Depository and Clearing Corporation [4].

Group 1 - The company, Mousse Co., announced a profit distribution plan based on a total share capital of approximately 393 million shares, excluding about 2.38 million repurchased shares, with a stock dividend of 1 share for every 10 shares held, totaling approximately 39.34 million shares to be distributed [2] - The company will not issue bonus shares or cash dividends, with the record date for the stock dividend set for August 20, 2025 [2] - For the year 2024, the company's revenue composition indicates that the furniture manufacturing sector accounts for 98.56% of total revenue, while other businesses contribute 1.44% [2]